Therapy of viral, mycoplasmal and rickettsial infections.
D000547:Amantadine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000188:drug therapy; D004917:Erythromycin / Q000627:therapeutic use; D006561:Herpes Simplex / Q000188:drug therapy; D006562:Herpes Zoster / Q000188:drug therapy; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007251:Influenza, Human / Q000188:drug therapy; D007372:Interferons / Q000627:therapeutic use; D009175:Mycoplasma Infections / Q000188:drug therapy*; D011213:Poxviridae Infections / Q000188:drug therapy; D011778:Q Fever / Q000188:drug therapy; D012282:Rickettsia Infections / Q000188:drug therapy*; D012373:Rocky Mountain Spotted Fever / Q000188:drug therapy; D013752:Tetracycline / Q000627:therapeutic use; D013882:Thiosemicarbazones / Q000627:therapeutic use; D014438:Typhus, Epidemic Louse-Borne / Q000188:drug therapy; D014777:Virus Diseases / Q000188:drug therapy*; D005719:gamma-Globulins / Q000627:therapeutic use
D000998:Antiviral Agents; D013882:Thiosemicarbazones; D005719:gamma-Globulins; D003561:Cytarabine; D004917:Erythromycin; D002701:Chloramphenicol; D007372:Interferons; D000547:Amantadine; D013752:Tetracycline; D007065:Idoxuridine